-
Edgewise Therapeutics Announces Pricing of $240 Million Underwritten Offering of Common Stock
-
Form SC 13G/A Edgewise Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Edgewise Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

